Publication | Closed Access

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions

ThrombosisVascular DiseaseIschemic StrokeCardiovascular DiseaseMedicineCerebrovascular DiseaseOther High-risk ConditionsHyperlipidemiaVascular BiologyDyslipidemiaNeurologyCerebral Blood FlowPublic HealthStrokeAtherosclerosisEpidemiology